
About Sofinnova
Sofinnova is a Financial Services company based in Paris (France). Life Sciences sector focused early stage VC firm investing primarily in Europe. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
A venture capital firm, Sofinnova Partners, is headquartered in Paris, France. Early-stage funding is provided to companies in the life sciences field, encompassing biopharma, medical devices, and biotech areas. Operations are centered in Europe, where innovative startups are supported through equity investments. Portfolio holdings include Ablynx, Nicox, Varioptic, and Addex Therapeutics, reflecting a commitment to sector growth.
- Headquarters Paris, France
- SectorsFinancial Services
- Website sofinnova.fr
Web traffic of Sofinnova
Websites that share an audience with Sofinnova (sofinnova.fr).
Websites whose visitors overlap most with Sofinnova. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| siparex.com | 100% | 6.8K | #3,062,909 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sofinnova
Complete news archive for Sofinnova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sofinnova
Sofinnova is headquartered in Paris, France.
A venture capital firm, Sofinnova Partners, is headquartered in Paris, France. Early-stage funding is provided to companies in the life sciences field, encompassing biopharma, medical devices, and biotech areas. Operations are centered in Europe, where innovative startups are supported through equity investments. Portfolio holdings include Ablynx, Nicox, Varioptic, and Addex Therapeutics, reflecting a commitment to sector growth.
